Hollsteen
← Alphabet

Research and development

Flow – sum over the period · $B

QuartersFiscal years

$BResearch and development · Q1 2016: $3.4B · 10-Q 0001652044-16-000021 filed May 3, 2016Research and development · Q2 2016: $3.4B · 10-Q 0001652044-16-000032 filed Aug 4, 2016Research and development · Q3 2016: $3.6B · 10-Q 0001652044-16-000038 filed Nov 3, 2016Research and development · Q4 2016: $3.6B · derived · 10-K 0001652044-18-000007 filed Feb 6, 2018Research and development · Q1 2017: $3.9B · 10-Q 0001652044-17-000014 filed May 2, 2017Research and development · Q2 2017: $4.2B · 10-Q 0001652044-17-000026 filed Jul 25, 2017Research and development · Q3 2017: $4.2B · 10-Q 0001652044-17-000042 filed Oct 27, 2017Research and development · Q4 2017: $4.3B · derived · 10-K 0001652044-19-000004 filed Feb 5, 2019Research and development · Q1 2018: $5.0B · 10-Q 0001652044-18-000016 filed Apr 24, 2018Research and development · Q2 2018: $5.1B · 10-Q 0001652044-18-000027 filed Jul 24, 2018Research and development · Q3 2018: $5.2B · 10-Q 0001652044-18-000035 filed Oct 26, 2018Research and development · Q4 2018: $6.0B · derived · 10-K 0001652044-20-000008 filed Feb 4, 2020Research and development · Q1 2019: $6.0B · 10-Q 0001652044-19-000015 filed Apr 30, 2019Research and development · Q2 2019: $6.2B · 10-Q 0001652044-19-000023 filed Jul 26, 2019Research and development · Q3 2019: $6.6B · 10-Q 0001652044-19-000032 filed Oct 29, 2019Research and development · Q4 2019: $7.2B · derived · 10-K 0001652044-21-000010 filed Feb 3, 2021Research and development · Q1 2020: $6.8B · 10-Q 0001652044-20-000021 filed Apr 29, 2020Research and development · Q2 2020: $6.9B · 10-Q 0001652044-20-000032 filed Jul 31, 2020Research and development · Q3 2020: $6.9B · 10-Q 0001652044-20-000050 filed Oct 30, 2020Research and development · Q4 2020: $7.0B · derived · 10-K 0001652044-22-000019 filed Feb 2, 2022Research and development · Q1 2021: $7.5B · 10-Q 0001652044-21-000020 filed Apr 28, 2021Research and development · Q2 2021: $7.7B · 10-Q 0001652044-21-000047 filed Jul 28, 2021Research and development · Q3 2021: $7.7B · 10-Q 0001652044-21-000057 filed Oct 27, 2021Research and development · Q4 2021: $8.7B · derived · 10-K 0001652044-23-000016 filed Feb 3, 2023Research and development · Q1 2022: $9.1B · 10-Q 0001652044-22-000029 filed Apr 27, 2022Research and development · Q2 2022: $9.8B · 10-Q 0001652044-22-000071 filed Jul 27, 2022Research and development · Q3 2022: $10.3B · 10-Q 0001652044-22-000090 filed Oct 26, 2022Research and development · Q4 2022: $10.3B · derived · 10-K 0001652044-24-000022 filed Jan 31, 2024Research and development · Q1 2023: $11.5B · 10-Q 0001652044-23-000045 filed Apr 26, 2023Research and development · Q2 2023: $10.6B · 10-Q 0001652044-23-000070 filed Jul 26, 2023Research and development · Q3 2023: $11.3B · 10-Q 0001652044-23-000094 filed Oct 25, 2023Research and development · Q4 2023: $12.1B · derived · 10-K 0001652044-25-000014 filed Feb 5, 2025Research and development · Q1 2024: $11.9B · 10-Q 0001652044-24-000053 filed Apr 26, 2024Research and development · Q2 2024: $11.9B · 10-Q 0001652044-24-000079 filed Jul 24, 2024Research and development · Q3 2024: $12.4B · 10-Q 0001652044-24-000118 filed Oct 30, 2024Research and development · Q4 2024: $13.1B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026Research and development · Q1 2025: $13.6B · 10-Q 0001652044-25-000043 filed Apr 25, 2025Research and development · Q2 2025: $13.8B · 10-Q 0001652044-25-000062 filed Jul 24, 2025Research and development · Q3 2025: $15.2B · 10-Q 0001652044-25-000091 filed Oct 30, 2025Research and development · Q4 2025: $18.6B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026Research and development · Q1 2026: $17.0B · 10-Q 0001652044-26-000048 filed Apr 30, 2026Research and development · Q2 2026: $18.2B · 10-Q 0001652044-26-000071 filed Jul 23, 20263.618.23.4Q1 2016Q2 2026
$BResearch and development · Q1 2016: $3.4B · 10-Q 0001652044-16-000021 filed May 3, 2016Research and development · Q2 2016: $3.4B · 10-Q 0001652044-16-000032 filed Aug 4, 2016Research and development · Q3 2016: $3.6B · 10-Q 0001652044-16-000038 filed Nov 3, 2016Research and development · Q4 2016: $3.6B · derived · 10-K 0001652044-18-000007 filed Feb 6, 2018Research and development · Q1 2017: $3.9B · 10-Q 0001652044-17-000014 filed May 2, 2017Research and development · Q2 2017: $4.2B · 10-Q 0001652044-17-000026 filed Jul 25, 2017Research and development · Q3 2017: $4.2B · 10-Q 0001652044-17-000042 filed Oct 27, 2017Research and development · Q4 2017: $4.3B · derived · 10-K 0001652044-19-000004 filed Feb 5, 20193.64.3a3.4Q1 2016Q4 2017Q3 2016
Q3 2016
3.6$B
All values (42)
PeriodValue ($B)Status
Q2 202618.2reported
Q1 202617.0reported
Q4 202518.6derived
Q3 202515.2reported
Q2 202513.8reported
Q1 202513.6reported
Q4 202413.1derived
Q3 202412.4reported
Q2 202411.9reported
Q1 202411.9reported
Q4 202312.1derived
Q3 202311.3reported
Q2 202310.6reported
Q1 202311.5reported
Q4 202210.3derived
Q3 202210.3reported
Q2 20229.8reported
Q1 20229.1reported
Q4 20218.7derived
Q3 20217.7reported
Q2 20217.7reported
Q1 20217.5reported
Q4 20207.0derived
Q3 20206.9reported
Q2 20206.9reported
Q1 20206.8reported
Q4 20197.2derived
Q3 20196.6reported
Q2 20196.2reported
Q1 20196.0reported
Q4 20186.0derived
Q3 20185.2reported
Q2 20185.1reported
Q1 20185.0reported
Q4 20174.3derived
Q3 20174.2reported
Q2 20174.2reported
Q1 20173.9reported
Q4 20163.6derived
Q3 20163.6reported
Q2 20163.4reported
Q1 20163.4reported

CSV with all sources · Technical ID: rnd

More metrics for Alphabet

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$3.6B
Period
Q3 2016, ended Sep 30, 2016 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Nov 3, 2016 · 0001652044-16-000038
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.6BNov 3, 201610-Q 0001652044-16-000038reported · confidence 1. · current